Commentary
The majority of NAFLD patients die of cardiovascular disease. For this reason, management of this condition requires a multidisciplinary team.
However, important misconceptions remain among primary care providers. NAFLD should be understood as part of a systemic disease characterized for abnormal accumulation of fat in tissues other than the adipose tissue, which produces organ dysfunctions.
This review by E. Godinez-Leiva et al. (University of Alabama, Birmingham, USA) “focuses on the extrahepatic manifestations of NAFLD and its metabolic and cardiovascular implications.”
Previous Post
Evidence linking obesity with MAFLD, NASH, and CVD
Next Post
NASH: prevalence and incidence of non-liver comorbidities in South Korea